Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neoplasms, Cystic, Mucinous, and Serous × Paclitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Carcinoma, Non-Small-Cell Lung 8 Ovarian Neoplasms 6 Fallopian Tube Neoplasms 5 Lung Neoplasms 4 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Stomach Neoplasms 2 Inflammatory Breast Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Ductal, Breast 2 Adenocarcinoma Of Esophagus 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 The Neoadjuvant Therapy 1 Recurrence 1 Primary Malignant Neoplasm of Ovary 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Neoplasms, Cystic, Mucinous, and Serous 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Hyperthermia 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 HER2-negative Breast Cancer 1 Epstein-Barr Virus Infections 1 Breast Carcinoma In Situ 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00689715 2016-07-26

EUS-EP

Asan Medical Center

Phase 2/3 Unknown

Neoplasms, Cystic, Mucinous, and Serous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡